These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17405496)

  • 1. [Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol].
    Ziegler R
    Med Monatsschr Pharm; 2007 Mar; 30(3):122-3. PubMed ID: 17405496
    [No Abstract]   [Full Text] [Related]  

  • 2. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    Kishimoto M; Oishi A; Motojima S
    N Engl J Med; 2006 Nov; 355(20):2156; author reply 2157. PubMed ID: 17108350
    [No Abstract]   [Full Text] [Related]  

  • 3. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    Minisola S; Scillitani A; Romagnoli E
    N Engl J Med; 2006 Nov; 355(20):2156-7; author reply 2157. PubMed ID: 17120352
    [No Abstract]   [Full Text] [Related]  

  • 4. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    de Nijs RN; Jacobs JW; Lems WF; Laan RF; Algra A; Huisman AM; Buskens E; de Laet CE; Oostveen AC; Geusens PP; Bruyn GA; Dijkmans BA; Bijlsma JW;
    N Engl J Med; 2006 Aug; 355(7):675-84. PubMed ID: 16914703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.
    Orimo H; Nakamura T; Fukunaga M; Ohta H; Hosoi T; Uemura Y; Kuroda T; Miyakawa N; Ohashi Y; Shiraki M;
    Curr Med Res Opin; 2011 Jun; 27(6):1273-84. PubMed ID: 21554143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis.
    Ringe JD; Schacht E; Dukas L; Mazor Z
    Arzneimittelforschung; 2011; 61(2):104-11. PubMed ID: 21428245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of renal transplant recipients with low bone mineral density: a randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol.
    Trabulus S; Altiparmak MR; Apaydin S; Serdengecti K; Sariyar M
    Transplant Proc; 2008; 40(1):160-6. PubMed ID: 18261575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study.
    Schacht E; Ringe JD
    Arzneimittelforschung; 2011; 61(1):40-54. PubMed ID: 21355445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of alendronate on glucocorticoid-induced osteoporosis].
    Zou X; Li Q; Shi C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):563-5. PubMed ID: 19587443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of bisphosphonates in women of child bearing age.
    McKenna M; Mansfield JC
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1214-5; author reply 1215-6. PubMed ID: 19473128
    [No Abstract]   [Full Text] [Related]  

  • 11. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
    Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
    Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis.
    Kitazaki S; Mitsuyama K; Masuda J; Harada K; Yamasaki H; Kuwaki K; Takedatsu H; Sugiyama G; Tsuruta O; Sata M
    Aliment Pharmacol Ther; 2009 Feb; 29(4):424-30. PubMed ID: 19035979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction. D-hormones alfacalcidol and calcitriol for prevention and treatment of glucocorticoid/inflammation-induced osteoporosis.
    Sambrook PN; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():1-3. PubMed ID: 16142844
    [No Abstract]   [Full Text] [Related]  

  • 15. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Babb RR
    N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol.
    Ringe JD; Schacht E
    Rheumatol Int; 2007 Dec; 28(2):103-11. PubMed ID: 17668216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis. Improving bone and muscle performance].
    MMW Fortschr Med; 2010 Dec; 152(48):36. PubMed ID: 21222333
    [No Abstract]   [Full Text] [Related]  

  • 18. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 19. High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial.
    Hoes JN; Jacobs JW; Hulsmans HM; De Nijs RN; Lems WF; Bruyn GA; Geusens PP; Bijlsma JW
    Clin Exp Rheumatol; 2010; 28(3):354-9. PubMed ID: 20406615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.